Effect of a monoclonal antibody against human relaxin-2 on cancer cell growth inhibition

被引：3
|
作者：
Park, Byoung Kwon [1 ,2 ]
Lee, Su In [2 ]
Lee, Younghee [3 ]
Cho, Sooyoung [4 ]
Lee, Young Seek [5 ]
Kwon, Hyung-Joo [1 ,2 ]
机构：
[1] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon 24252, South Korea
[2] Hallym Univ, Coll Med, Dept Microbiol, Chunchon 24252, South Korea
[3] Chungbuk Natl Univ, Dept Biochem, Coll Nat Sci, Cheongju 28644, South Korea
[4] Seoul Natl Univ, Res Inst Vet Sci BK21, Lab Dev Biol & Genom, Coll Vet Med,Program Vet Sci, Seoul 08826, South Korea
[5] Hanyang Univ, Div Mol & Life Sci, Coll Sci & Technol, Ansan 15588, South Korea
来源：
APPLIED BIOLOGICAL CHEMISTRY | 2016年 / 59卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
Cancer; Monoclonal antibody; Relaxin-2; DNA-LIPOSOME COMPLEX; XENOGRAFT TUMOR-GROWTH; CPG-DNA; INCREASES SECRETION; CERVICAL GROWTH; IN-VIVO; PROGRESSION; EXPRESSION; PIG; OSTEOSARCOMA;
D O I：
10.1007/s13765-016-0221-4
中图分类号：
TS2 [食品工业];
学科分类号：
0832 ;
摘要：
Relaxin-2 has gained much attention because of its importance in cancer cell proliferation, invasion, and angiogenesis. However, the potential of relaxin-2 as a target for immunotherapy has never been directly validated before. In the present study, we produced a human relaxin-2-specific antibody by immunizing mice using a specific liposome complex containing relaxin-2 epitope peptide and CpG-DNA. We isolated a hybridoma clone, 1B11F12, producing the anti-relaxin-2 monoclonal antibody. We confirmed with immunoprecipitation analysis that the antibody specifically recognizes native human relaxin-2. Treatment with the antibody suppressed the growth of some cancer cell lines. Therefore, we suggest that relaxin-2 could be a reasonable target of cancer therapeutics, and the monoclonal antibody could be used to treat cancer in humans.
引用
收藏
页码：739 / 746
页数：8
相关论文
共 50 条
  • [21] Autoregulation of human relaxin-2 critically involves relaxin, glucocorticoid receptor and stat5 binding to glucocorticoid response half-sites in the relaxin-2 promoter
    Dschietzig, T.
    Bartsch, C.
    Baumann, G.
    Stangl, K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 39 - 39
  • [22] Human Relaxin-2: Design, Synthesis and Development of Novel Antagonists
    Nair, V. B.
    Samuel, C. S.
    Separovic, F.
    Wade, J. D.
    Hossain, M. A.
    BIOPOLYMERS, 2013, 100 (03) : 284 - 284
  • [23] Solution Structure, Aggregation Behavior, and Flexibility of Human Relaxin-2
    Haugaard-Kedstrom, Linda M.
    Hossain, Mohammed Akhter
    Daly, Norelle L.
    Bathgate, Ross A. D.
    Rinderknecht, Ernst
    Wade, John D.
    Craik, David J.
    Rosengren, K. Johan
    ACS CHEMICAL BIOLOGY, 2015, 10 (03) : 891 - 900
  • [24] Monoclonal antibody against human growth hormone receptor
    Lattuada, D
    Casnici, C
    Perego, C
    Testorelli, C
    Berrini, A
    Tonon, G
    Marelli, O
    HYBRIDOMA, 2000, 19 (02): : 177 - 183
  • [25] INHIBITION OF SPERM MOTILITY BY AN ANTI-HUMAN RELAXIN MONOCLONAL-ANTIBODY - VIDEOMICROGRAPHIC ANALYSIS
    SOKOL, RZ
    OKUDA, H
    JOHNSON, P
    SWERDLOFF, RS
    CLINICAL RESEARCH, 1987, 35 (01): : A123 - A123
  • [26] The influence of amphotericin B and neomycin on the effect of human relaxin-2 on foetal membranes and isolated myometrium
    Vogel, I
    Gronbæk, H
    Uldbjerg, N
    Forman, A
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 94 (03) : 144 - 150
  • [27] Acute and subacute functional effects of relaxin-2 on human mammary artery
    Francisco Pereira Goncalves, F.
    Martins, R.
    Mendonca, L.
    Santos, T. Laundos
    Pintalhao, M.
    Novoa, F. Vasques
    Pinho, P.
    Amorim, M. J.
    Nascimento, D. S.
    Moreira, A. Leite
    Chaves, P. Castro
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 166 - 166
  • [28] Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer
    Tevz, Gregor
    McGrath, Sean
    Demeter, Ryan
    Magrini, Vincent
    Jeet, Varinder
    Rockstroh, Anja
    McPherson, Stephen
    Lai, John
    Bartonicek, Nenad
    An, Jiyuan
    Batra, Jyotsna
    Dinger, Marcel E.
    Lehman, Melanie L.
    Williams, Elizabeth D.
    Nelson, Colleen C.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 420 (0C) : 159 - 168
  • [29] Further Developments towards a Minimal Potent Derivative of Human Relaxin-2
    Handley, Thomas N. G.
    Praveen, Praveen
    Tailhades, Julien
    Wu, Hongkang
    Bathgate, Ross A. D.
    Hossain, Mohammed Akhter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [30] A novel human monoclonal antibody derived from tumor infiltrating lymphocytes in gastric cancer specific to cancer cells with cell growth inhibition
    Nakamura, Rieko
    Saikawa, Yoshiro
    Hosokawa, Saiko
    Fukuda, Kazumasa
    Kumai, Koichiro
    Kubota, Tetsuro
    Kitajima, Masaki
    CANCER RESEARCH, 2006, 66 (08)
12345